My team just got back to the States from the land of unlimited pot stock potential: Canada.
Organizers estimated some 15,000 growers, researchers, retailers, policymakers, industry insiders, and enthusiasts attended a "double-header" - a business conference and cannabis expo that proved to be the biggest single-day weed-centric event in Canada's history and the largest in North America today.
Eric Costen, director general of Canada's Cannabis Legalization and Regulation Secretariat, opened the proceedings with a bang when he said, "The eyes of the world are watching Canada," and reaffirmed Parliament's commitment to a June 7 legalization vote.
The bill, which has the enthusiastic backing of Canadian Prime Minister Justin Trudeau, is widely expected to pass with flying colors.
Once the Queen's representative, Gov. General Julie Payette, grants royal assent, it'll be official: Canada will have a fully legalized, regulated recreational marijuana market.
You see, I fully expect Canada's weed market to grow 20 times larger over the next decade. It's hard to overstate the potential for investment riches.
I've got good company: Statista estimates the Canadian cannabis retail sector - a relatively small chunk of the broader market - could top $2.8 billion by 2020.
In the "big picture," Deloitte expects the growers, value-added product markets, laboratories, security, tourism, exports, and all the other related segments could surge to $22.6 billion before much longer.
That's why we're watching this event so closely. It would've been unthinkable to miss out.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.
I agree Mark – Canada will legalize sometime this summer – early fall. My big fear is all of the retail investors jumping in will be easy targets for the Wall St. investment houses traders who will short the stocks and then start posting a bunch of misinformation to drive the cannabis stock price down.
The un-informed retail investor will get jittery and jump out – and the steamroll effect will begin.
My concern as with many or most businesses is what they don't tell you…..the hype is always there, until you buy into what they are selling and then find out the nitty gritty details. So, having searched and read emails on the subject of marijuana, I decided on penny stocks. With the medical there are suppliers of packaging, bottles, syringes, etc. I have found 4 companies that I have invested $50. in each and see where it goes without investing in programs. I might not see 10,000 percent returns but i will be satisfied that I wasn't blind sided.
I'm onboard. Through your publication I've picked up some stocks that look to pay off quite handsomely in the very near future. I jumped in the deep end and invested in a major Canada multi-product venture and I think that will be very lucrative as well. Just ordered Phase 2 of the Marijuana Millionaire and enjoying being a member of the club.
My style of investing hs helped me to update my portfolio to a new level. I always start with a $1000 buy in to a stock Michael brought to my attention. Imagine my happiness with Orbotech, AMD or Red Hat Inc. I owe these investments to Michael Robinson's studies and a BIG thank you! Start at $1000 per investment. It's easy to figure out about what you may make off of that trade or buy. I understand if not all of you can start at that level, but I technically can't either, being that if I lose BIG on any one stock, dollars are flying out of the window. So far, so good!
I started buying Cannabis stocks last June 2017. My total investment is over $75000 and I have already made $38700!!! Missed on one stock by selling at a mere 240% several times but if I would have held on to the 2000 shares I would have made over $56,000!! This area has really been exciting and nerve racking at the same time. Looking forward to the next couple of years.
I TRUELY TRUST YOUR KNOWLEDGE
we all know this will happen . now is the time its going to move fast.
get you some!!!
What brokerage can a person deal with to enter into any pot related trades? Could not do it with the brokerage through my bank.
I use TD Ameritrade with no problems